acetylcarnitine has been researched along with Acute Confusional Senile Dementia in 44 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study was aimed at exploring the role of Acetyl L-Carnitine supplementation attenuating dementia and degradation of cognitive abilities in Hyperhomocysteinemia induced AD manifestations in the mouse model." | 8.02 | Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model. ( Gupta, JK; Srivastava, R; Varshney, KK; Verma, N, 2021) |
| " Hyperhomocysteinemia causes excitotoxicity to the cortical neurons, which brought us to the point that amino acids possibly have a role in causing cholinergic deformities, which are an important etiological parameter in AD." | 8.02 | Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model. ( Gupta, JK; Srivastava, R; Varshney, KK; Verma, N, 2021) |
| "The objective of the present investigation was to investigate and evaluate the pharmacological effect of Acetyl L-Carnitine against hyperhomocysteinemia induced Alzheimer's disease (AD) in the mouse model." | 8.02 | Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model. ( Gupta, JK; Srivastava, R; Varshney, KK; Verma, N, 2021) |
| "The acute effects of intravenously administered L-acetylcarnitine (LAC) were evaluated with single-photon emission computed tomography (SPECT) and 99mTc-hexamethylpropyleneamine oxime in 30 demented patients (21 with a clinical diagnosis of Alzheimer's dementia and 9 with mixed-type dementia)." | 7.67 | Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine. ( Battistin, L; Borsato, N; Calvani, M; Da Col, C; Dam, M; Ferlin, G; Perlotto, N; Pizzolato, G; Saitta, B, 1989) |
| "The trials were identified from a search of the Specialized Register of the Cochrane Dementia and Cognitive Improvement Group on 8 January 2003 using the terms acetyl-l-carnitine, l-carnitine acetyl ester, acetylcarnitine." | 4.82 | Acetyl-L-carnitine for dementia. ( Hudson, S; Tabet, N, 2003) |
| "The study was aimed at exploring the role of Acetyl L-Carnitine supplementation attenuating dementia and degradation of cognitive abilities in Hyperhomocysteinemia induced AD manifestations in the mouse model." | 4.02 | Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model. ( Gupta, JK; Srivastava, R; Varshney, KK; Verma, N, 2021) |
| " Hyperhomocysteinemia causes excitotoxicity to the cortical neurons, which brought us to the point that amino acids possibly have a role in causing cholinergic deformities, which are an important etiological parameter in AD." | 4.02 | Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model. ( Gupta, JK; Srivastava, R; Varshney, KK; Verma, N, 2021) |
| "The objective of the present investigation was to investigate and evaluate the pharmacological effect of Acetyl L-Carnitine against hyperhomocysteinemia induced Alzheimer's disease (AD) in the mouse model." | 4.02 | Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model. ( Gupta, JK; Srivastava, R; Varshney, KK; Verma, N, 2021) |
| "The acute effects of intravenously administered L-acetylcarnitine (LAC) were evaluated with single-photon emission computed tomography (SPECT) and 99mTc-hexamethylpropyleneamine oxime in 30 demented patients (21 with a clinical diagnosis of Alzheimer's dementia and 9 with mixed-type dementia)." | 3.67 | Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine. ( Battistin, L; Borsato, N; Calvani, M; Da Col, C; Dam, M; Ferlin, G; Perlotto, N; Pizzolato, G; Saitta, B, 1989) |
| "ALC slows the progression of Alzheimer's disease in younger subjects, and the use of the trilinear approach to estimate the average rate of change may prove valuable in pharmacological trials." | 2.69 | Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach. ( Bravi, D; Brooks, JO; Carta, A; Yesavage, JA, 1998) |
| "Primary outcome measures were the Alzheimer's Disease Assessment Scale-Cognitive Component and the Clinical Dementia Rating Scale." | 2.69 | A 1-year controlled trial of acetyl-l-carnitine in early-onset AD. ( Amato, A; Calvani, M; Carta, A; Thal, LJ, 2000) |
| "L-Carnitine is an essential co-factor in the metabolism of lipids and consequently in the production of cellular energy." | 2.44 | [Physiological functions of carnitine and carnitine transporters in the central nervous system]. ( Inazu, M; Matsumiya, T, 2008) |
| "Dementia is a common mental health problem affecting 5% of those over 65." | 2.42 | Acetyl-L-carnitine for dementia. ( Hudson, S; Tabet, N, 2003) |
| "The progression of Alzheimer's disease (AD) is accompanied by disturbances of the endosome/lysosome (EL) system and there is accumulation of peptides of the AD-associated amyloid beta (Abeta) type in EL vesicles of affected neurons." | 1.38 | Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells. ( Chen, L; Fuchs, PM; Kanazirska, MV; Lal, S; Vassilev, PM; Verma, J, 2012) |
| "Pathological hallmarks of Alzheimer's disease are potentially linked to alterations of the axonal compartments." | 1.35 | Up-regulation of kinesin light-chain 1 gene expression by acetyl-L-carnitine: therapeutic possibility in Alzheimer's disease. ( Brunelli, M; Federighi, G; Traina, G, 2008) |
| " GSH plays a key role in antioxidant defense, and HNE exposure causes an initial depletion of GSH that leads to gradual toxic accumulation of reactive oxygen species." | 1.34 | Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease. ( Abdul, HM; Butterfield, DA, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (9.09) | 18.7374 |
| 1990's | 14 (31.82) | 18.2507 |
| 2000's | 16 (36.36) | 29.6817 |
| 2010's | 6 (13.64) | 24.3611 |
| 2020's | 4 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Verma, N | 1 |
| Gupta, JK | 1 |
| Varshney, KK | 1 |
| Srivastava, R | 1 |
| Qutob, HMH | 1 |
| Saad, RA | 1 |
| Bali, H | 1 |
| Osailan, A | 1 |
| Jaber, J | 1 |
| Alzahrani, E | 1 |
| Alyami, J | 1 |
| Elsayed, H | 1 |
| Alserihi, R | 1 |
| Shaikhomar, OA | 1 |
| Divya, KM | 1 |
| Savitha, DP | 1 |
| Krishna, GA | 1 |
| Dhanya, TM | 1 |
| Mohanan, PV | 1 |
| Shah, SF | 1 |
| Jafry, AT | 1 |
| Hussain, G | 1 |
| Kazim, AH | 1 |
| Ali, M | 1 |
| Rivani, E | 1 |
| Endraswari, PD | 1 |
| Widodo, ADW | 1 |
| Khalil, MR | 1 |
| Guldberg, R | 1 |
| Nørgård, BM | 1 |
| Uldbjerg, N | 1 |
| Wehberg, S | 1 |
| Fowobaje, KR | 1 |
| Mashood, LO | 1 |
| Ekholuenetale, M | 1 |
| Ibidoja, OJ | 1 |
| Romagnoli, A | 1 |
| D'Agostino, M | 1 |
| Pavoni, E | 1 |
| Ardiccioni, C | 1 |
| Motta, S | 1 |
| Crippa, P | 1 |
| Biagetti, G | 1 |
| Notarstefano, V | 1 |
| Rexha, J | 1 |
| Perta, N | 1 |
| Barocci, S | 1 |
| Costabile, BK | 1 |
| Colasurdo, G | 1 |
| Caucci, S | 1 |
| Mencarelli, D | 1 |
| Turchetti, C | 1 |
| Farina, M | 1 |
| Pierantoni, L | 1 |
| La Teana, A | 1 |
| Al Hadi, R | 1 |
| Cicconardi, F | 1 |
| Chinappi, M | 1 |
| Trucchi, E | 1 |
| Mancia, F | 1 |
| Menzo, S | 1 |
| Morozzo Della Rocca, B | 1 |
| D'Annessa, I | 1 |
| Di Marino, D | 1 |
| Choya, A | 1 |
| de Rivas, B | 1 |
| Gutiérrez-Ortiz, JI | 1 |
| López-Fonseca, R | 1 |
| Xu, S | 1 |
| Cheng, B | 1 |
| Huang, Z | 1 |
| Liu, T | 1 |
| Li, Y | 1 |
| Jiang, L | 1 |
| Guo, W | 1 |
| Xiong, J | 1 |
| Amirazodi, M | 1 |
| Daryanoosh, F | 1 |
| Mehrabi, A | 1 |
| Gaeini, A | 1 |
| Koushkie Jahromi, M | 1 |
| Salesi, M | 1 |
| Zarifkar, AH | 1 |
| Studeny, P | 1 |
| Netukova, M | 1 |
| Nemcokova, M | 1 |
| Klimesova, YM | 1 |
| Krizova, D | 1 |
| Kang, H | 1 |
| Tao, Y | 1 |
| Zhang, Q | 1 |
| Sha, D | 1 |
| Chen, Y | 1 |
| Yao, J | 1 |
| Gao, Y | 1 |
| Liu, J | 3 |
| Ji, L | 1 |
| Shi, P | 1 |
| Shi, C | 1 |
| Wu, YL | 1 |
| Wright, AI | 1 |
| M El-Metwaly, N | 1 |
| A Katouah, H | 1 |
| El-Desouky, MG | 1 |
| El-Bindary, AA | 1 |
| El-Bindary, MA | 1 |
| Kostakis, ID | 1 |
| Raptis, DA | 1 |
| Davidson, BR | 1 |
| Iype, S | 1 |
| Nasralla, D | 1 |
| Imber, C | 1 |
| Sharma, D | 1 |
| Pissanou, T | 1 |
| Pollok, JM | 1 |
| Hughes, AM | 1 |
| Sanderson, E | 1 |
| Morris, T | 1 |
| Ayorech, Z | 1 |
| Tesli, M | 1 |
| Ask, H | 1 |
| Reichborn-Kjennerud, T | 1 |
| Andreassen, OA | 1 |
| Magnus, P | 1 |
| Helgeland, Ø | 1 |
| Johansson, S | 1 |
| Njølstad, P | 1 |
| Davey Smith, G | 1 |
| Havdahl, A | 1 |
| Howe, LD | 1 |
| Davies, NM | 1 |
| Amrillah, T | 1 |
| Prasetio, A | 1 |
| Supandi, AR | 1 |
| Sidiq, DH | 1 |
| Putra, FS | 1 |
| Nugroho, MA | 1 |
| Salsabilla, Z | 1 |
| Azmi, R | 1 |
| Grammatikopoulos, P | 1 |
| Bouloumis, T | 1 |
| Steinhauer, S | 1 |
| Mironov, VS | 2 |
| Bazhenova, TA | 2 |
| Manakin, YV | 2 |
| Yagubskii, EB | 2 |
| Yakushev, IA | 1 |
| Gilmutdinov, IF | 1 |
| Simonov, SV | 1 |
| Lan, K | 1 |
| Yang, H | 1 |
| Zheng, J | 1 |
| Hu, H | 1 |
| Zhu, T | 1 |
| Zou, X | 1 |
| Hu, B | 1 |
| Liu, H | 1 |
| Olokede, O | 1 |
| Wu, H | 1 |
| Holtzapple, M | 1 |
| Gungor, O | 1 |
| Kose, M | 1 |
| Ghaemi, R | 1 |
| Acker, M | 1 |
| Stosic, A | 1 |
| Jacobs, R | 1 |
| Selvaganapathy, PR | 1 |
| Ludwig, N | 1 |
| Yerneni, SS | 1 |
| Azambuja, JH | 1 |
| Pietrowska, M | 1 |
| Widłak, P | 1 |
| Hinck, CS | 1 |
| Głuszko, A | 1 |
| Szczepański, MJ | 1 |
| Kärmer, T | 1 |
| Kallinger, I | 1 |
| Schulz, D | 1 |
| Bauer, RJ | 1 |
| Spanier, G | 1 |
| Spoerl, S | 1 |
| Meier, JK | 1 |
| Ettl, T | 1 |
| Razzo, BM | 1 |
| Reichert, TE | 1 |
| Hinck, AP | 1 |
| Whiteside, TL | 1 |
| Wei, ZL | 1 |
| Juan, W | 1 |
| Tong, D | 1 |
| Juan, LX | 1 |
| Sa, LY | 1 |
| Jie, HFM | 1 |
| Xiao, G | 1 |
| Xiang, LG | 1 |
| Jie, HM | 1 |
| Xu, C | 1 |
| Yu, DN | 1 |
| Yao, ZX | 1 |
| Bigdeli, F | 1 |
| Gao, XM | 1 |
| Cheng, X | 1 |
| Li, JZ | 1 |
| Zhang, JW | 1 |
| Wang, W | 2 |
| Guan, ZJ | 1 |
| Bu, Y | 1 |
| Liu, KG | 1 |
| Morsali, A | 1 |
| Das, R | 1 |
| Paul, R | 1 |
| Parui, A | 1 |
| Shrotri, A | 1 |
| Atzori, C | 1 |
| Lomachenko, KA | 1 |
| Singh, AK | 1 |
| Mondal, J | 1 |
| Peter, SC | 1 |
| Florimbio, AR | 1 |
| Coughlin, LN | 1 |
| Bauermeister, JA | 1 |
| Young, SD | 1 |
| Zimmerman, MA | 1 |
| Walton, MA | 1 |
| Bonar, EE | 1 |
| Demir, D | 1 |
| Balci, AB | 1 |
| Kahraman, N | 1 |
| Sunbul, SA | 1 |
| Gucu, A | 1 |
| Seker, IB | 1 |
| Badem, S | 1 |
| Yuksel, A | 1 |
| Ozyazicioglu, AF | 1 |
| Goncu, MT | 1 |
| Zhang, H | 1 |
| Zhou, H | 1 |
| Deng, Z | 1 |
| Luo, L | 1 |
| Ong, SP | 1 |
| Wang, C | 1 |
| Xin, H | 1 |
| Whittingham, MS | 1 |
| Zhou, G | 1 |
| Maemura, R | 1 |
| Wakamatsu, M | 1 |
| Matsumoto, K | 1 |
| Sakaguchi, H | 1 |
| Yoshida, N | 1 |
| Hama, A | 1 |
| Yoshida, T | 1 |
| Miwata, S | 1 |
| Kitazawa, H | 1 |
| Narita, K | 1 |
| Kataoka, S | 1 |
| Ichikawa, D | 1 |
| Hamada, M | 1 |
| Taniguchi, R | 1 |
| Suzuki, K | 1 |
| Kawashima, N | 1 |
| Nishikawa, E | 1 |
| Narita, A | 1 |
| Okuno, Y | 1 |
| Nishio, N | 1 |
| Kato, K | 1 |
| Kojima, S | 1 |
| Morita, K | 1 |
| Muramatsu, H | 1 |
| Takahashi, Y | 1 |
| Yirgu, A | 1 |
| Mekonnen, Y | 1 |
| Eyado, A | 1 |
| Staropoli, A | 1 |
| Vinale, F | 1 |
| Zac, J | 1 |
| Zac, S | 1 |
| Pérez-Padilla, R | 1 |
| Remigio-Luna, A | 1 |
| Guzmán-Boulloud, N | 1 |
| Gochicoa-Rangel, L | 1 |
| Guzmán-Valderrábano, C | 1 |
| Thirión-Romero, I | 1 |
| Statsenko, ME | 1 |
| Turkina, SV | 1 |
| Barantsevich, ER | 1 |
| Karakulova, YV | 1 |
| Baranova, NS | 1 |
| Morzhukhina, MV | 1 |
| Wang, Q | 2 |
| Gu, Y | 1 |
| Chen, C | 1 |
| Qiao, L | 1 |
| Pan, F | 1 |
| Song, C | 1 |
| Canetto, SS | 1 |
| Entilli, L | 1 |
| Cerbo, I | 1 |
| Cipolletta, S | 1 |
| Wu, Y | 2 |
| Zhu, P | 1 |
| Jiang, Y | 1 |
| Zhang, X | 1 |
| Wang, Z | 1 |
| Xie, B | 1 |
| Song, T | 1 |
| Zhang, F | 1 |
| Luo, A | 1 |
| Li, S | 1 |
| Xiong, X | 1 |
| Han, J | 1 |
| Peng, X | 1 |
| Li, M | 1 |
| Huang, L | 1 |
| Chen, Q | 1 |
| Fang, W | 1 |
| Hou, Y | 1 |
| Zhu, Y | 1 |
| Ye, J | 1 |
| Liu, L | 1 |
| Islam, MR | 1 |
| Sanderson, P | 1 |
| Johansen, MP | 1 |
| Payne, TE | 1 |
| Naidu, R | 1 |
| Cao, J | 1 |
| Yang, J | 1 |
| Niu, X | 1 |
| Liu, X | 1 |
| Zhai, Y | 1 |
| Qiang, C | 1 |
| Niu, Y | 1 |
| Li, Z | 1 |
| Dong, N | 1 |
| Wen, B | 1 |
| Ouyang, Z | 1 |
| Zhang, Y | 1 |
| Li, J | 2 |
| Zhao, M | 1 |
| Zhao, J | 1 |
| Morici, P | 1 |
| Rizzato, C | 1 |
| Ghelardi, E | 1 |
| Rossolini, GM | 1 |
| Lupetti, A | 1 |
| Gözüküçük, R | 1 |
| Cakiroglu, B | 1 |
| He, X | 1 |
| Li, R | 1 |
| Zhao, D | 1 |
| Zhang, L | 1 |
| Ji, X | 1 |
| Fan, X | 1 |
| Chen, J | 1 |
| Wang, Y | 1 |
| Luo, Y | 1 |
| Zheng, D | 1 |
| Xie, L | 1 |
| Sun, S | 1 |
| Cai, Z | 1 |
| Liu, Q | 1 |
| Ma, K | 1 |
| Sun, X | 1 |
| Drinkwater, JJ | 1 |
| Davis, TME | 1 |
| Turner, AW | 1 |
| Davis, WA | 1 |
| Suzuki, Y | 1 |
| Mizuta, Y | 1 |
| Mikagi, A | 1 |
| Misawa-Suzuki, T | 1 |
| Tsuchido, Y | 1 |
| Sugaya, T | 1 |
| Hashimoto, T | 1 |
| Ema, K | 1 |
| Hayashita, T | 1 |
| Maldonado, C | 1 |
| Vázquez, M | 1 |
| Fagiolino, P | 1 |
| Mota, SI | 1 |
| Pita, I | 1 |
| Águas, R | 1 |
| Tagorti, S | 1 |
| Virmani, A | 1 |
| Pereira, FC | 1 |
| Rego, AC | 1 |
| Sergi, G | 1 |
| Pizzato, S | 1 |
| Piovesan, F | 1 |
| Trevisan, C | 1 |
| Veronese, N | 1 |
| Manzato, E | 1 |
| Bigford, GE | 1 |
| Del Rossi, G | 1 |
| Inazu, M | 1 |
| Matsumiya, T | 1 |
| Traina, G | 1 |
| Federighi, G | 1 |
| Brunelli, M | 1 |
| Suchy, J | 1 |
| Chan, A | 1 |
| Shea, TB | 1 |
| Shenk, JC | 1 |
| Fischbach, K | 1 |
| Xu, K | 1 |
| Puchowicz, M | 1 |
| Obrenovich, ME | 1 |
| Gasimov, E | 1 |
| Alvarez, LM | 1 |
| Ames, BN | 2 |
| Lamanna, JC | 1 |
| Aliev, G | 1 |
| Zhou, P | 1 |
| Chen, Z | 1 |
| Zhao, N | 1 |
| Liu, D | 1 |
| Guo, ZY | 1 |
| Tan, L | 1 |
| Hu, J | 1 |
| Wang, JZ | 1 |
| Zhu, LQ | 1 |
| Gavrilova, SI | 1 |
| Kalyn, IaB | 1 |
| Kolykhalov, IV | 1 |
| Roshchina, IF | 1 |
| Selezneva, ND | 1 |
| Kanazirska, MV | 1 |
| Fuchs, PM | 1 |
| Chen, L | 1 |
| Lal, S | 1 |
| Verma, J | 1 |
| Vassilev, PM | 1 |
| Montgomery, SA | 1 |
| Thal, LJ | 3 |
| Amrein, R | 1 |
| Gold, PE | 1 |
| Cahill, L | 1 |
| Wenk, GL | 1 |
| Hudson, S | 1 |
| Tabet, N | 1 |
| Bianchetti, A | 1 |
| Rozzini, R | 1 |
| Trabucchi, M | 1 |
| Shen, ZX | 1 |
| Abdul, HM | 2 |
| Calabrese, V | 2 |
| Calvani, M | 7 |
| Butterfield, DA | 4 |
| Mancuso, C | 1 |
| Bates, TE | 1 |
| Calafato, S | 1 |
| Cornelius, C | 1 |
| De Lorenzo, A | 1 |
| Dinkova Kostova, AT | 1 |
| Acierno, G | 1 |
| Forloni, G | 2 |
| Angeretti, N | 1 |
| Smiroldo, S | 1 |
| Carta, A | 6 |
| Bravi, D | 2 |
| Bhuachalla, SN | 1 |
| Rangachari, A | 1 |
| Terwel, D | 1 |
| Prickaerts, J | 1 |
| Meng, F | 1 |
| Jolles, J | 1 |
| Clarke, WR | 1 |
| Ferris, SH | 1 |
| Friedland, RP | 1 |
| Petersen, RC | 1 |
| Pettegrew, JW | 2 |
| Pfeiffer, E | 1 |
| Raskind, MA | 1 |
| Sano, M | 2 |
| Tuszynski, MH | 1 |
| Woolson, RF | 1 |
| Brooks, JO | 1 |
| Yesavage, JA | 1 |
| Amato, A | 1 |
| Levine, J | 1 |
| McClure, RJ | 1 |
| Barrett, AM | 1 |
| Bell, K | 1 |
| Cote, L | 1 |
| Dooneief, G | 1 |
| Lawton, A | 1 |
| Legler, L | 1 |
| Marder, K | 1 |
| Naini, A | 1 |
| Stern, Y | 1 |
| Mayeux, R | 1 |
| Caruso, G | 1 |
| Benedetti, N | 1 |
| Iannuccelli, M | 1 |
| Parnetti, L | 1 |
| Gaiti, A | 1 |
| Mecocci, P | 1 |
| Cadini, D | 1 |
| Senin, U | 1 |
| Bowman, BA | 1 |
| Spagnoli, A | 2 |
| Lucca, U | 2 |
| Menasce, G | 2 |
| Bandera, L | 1 |
| Cizza, G | 2 |
| Tettamanti, M | 1 |
| Frattura, L | 2 |
| Tiraboschi, P | 2 |
| Comelli, M | 2 |
| Rai, G | 1 |
| Wright, G | 1 |
| Scott, L | 1 |
| Beston, B | 1 |
| Rest, J | 1 |
| Exton-Smith, AN | 1 |
| Gambi, D | 1 |
| Onofrj, M | 1 |
| Faricelli, A | 1 |
| Del Re, ML | 1 |
| Bazzano, S | 1 |
| Cutarella, R | 1 |
| Fulgente, T | 1 |
| Colangelo, U | 1 |
| Bressi, S | 1 |
| Battistin, L | 1 |
| Pizzolato, G | 1 |
| Dam, M | 1 |
| Da Col, C | 1 |
| Perlotto, N | 1 |
| Saitta, B | 1 |
| Borsato, N | 1 |
| Ferlin, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Clinical Trial of a Vitamin/Nutriceutical Formulation for Alzheimer's Disease[NCT01320527] | Phase 2 | 135 participants (Actual) | Interventional | 2008-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for acetylcarnitine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter | 2022 |
Effects of acetyl-L-carnitine in diabetic neuropathy and other geriatric disorders.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Analgesics; Diabetic Neuropathies; Humans; Mitochondria; P | 2018 |
Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.
Topics: Acetylcarnitine; Alzheimer Disease; Brain; Brain Injuries; Cinnamates; Cognition Disorders; Curcumin | 2014 |
[Physiological functions of carnitine and carnitine transporters in the central nervous system].
Topics: Acetylcarnitine; Alzheimer Disease; Astrocytes; Brain; Carnitine; Choline; Energy Metabolism; Ketone | 2008 |
Acetyl-L-carnitine. Monograph.
Topics: Acetylcarnitine; Alcoholism; Alzheimer Disease; Attention Deficit Disorder with Hyperactivity; Cogni | 2010 |
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Cognition; Humans; Nootropic Agents; Prospective Studies; | 2003 |
Acetyl-L-carnitine for dementia.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Dementia; Humans; Nootropic Agents; Randomized Controlled | 2003 |
Delaying the mitochondrial decay of aging with acetylcarnitine.
Topics: Acetylcarnitine; Aging; Alzheimer Disease; Animals; Brain; Carnitine; Dose-Response Relationship, Dr | 2004 |
Natural antioxidants in Alzheimer's disease.
Topics: Acetylcarnitine; Alzheimer Disease; Animals; Antioxidants; Cholinesterase Inhibitors; Humans; Neurop | 2007 |
Acetyl-L-carnitine and Alzheimer's disease: pharmacological considerations beyond the cholinergic sphere.
Topics: Acetylcarnitine; Aging; Alzheimer Disease; Animals; Brain; Carnitine O-Acetyltransferase; Humans; Mi | 1993 |
Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Animals; Brain; Depression; Energy Metabolism; Humans | 2000 |
Acetyl-carnitine and Alzheimer's disease.
Topics: Acetylcarnitine; Alzheimer Disease; Double-Blind Method; Humans | 1992 |
14 trials available for acetylcarnitine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter | 2022 |
[Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia].
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Dementia, Vascular; Drug Administration Schedule; Female; | 2011 |
Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Drug The | 2003 |
[The use of 1-acetylcarnitine in (presenile and senile) Alzheimer's disease. Preliminary results].
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carnitine; Clinical Trials as Topic; Dementia; Double-Blin | 1983 |
A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Double-Blind Method; Female; Humans; Male; Middle Aged | 1996 |
Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach.
Topics: Acetylcarnitine; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Cognition Disorders; Disea | 1998 |
A 1-year controlled trial of acetyl-l-carnitine in early-onset AD.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Mu | 2000 |
Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Double-Blind Method; Humans; Memory; Middle Aged; Neuropsy | 1992 |
Action of acetyl-L-carnitine in neurodegeneration and Alzheimer's disease.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Double-Blind Method; Female; Humans; Male; Nerve Degenerat | 1992 |
Acetyl-carnitine and Alzheimer's disease.
Topics: Acetylcarnitine; Alzheimer Disease; Double-Blind Method; Humans | 1992 |
Acetyl-L-carnitine: a drug able to slow the progress of Alzheimer's disease?
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Double-Blind Method; Female; Humans; Male; Placebos | 1991 |
Long-term acetyl-L-carnitine treatment in Alzheimer's disease.
Topics: Acetylcarnitine; Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Varia | 1991 |
Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia.
Topics: Acetylcarnitine; Activities of Daily Living; Aged; Alzheimer Disease; Carnitine; Double-Blind Method | 1990 |
An example of a clinical trial in patients with Alzheimer's disease: some methodological issues.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carnitine; Clinical Trials as Topic; Double-Blind Method; | 1989 |
20 other studies available for acetylcarnitine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Ameliorative Effect of Acetyl L-carnitine in Alzheimer's Disease via Downregulating of Homocysteine Levels in Hyperhomocysteinemia Induced Cognitive Deficit in Mouse Model.
Topics: Acetylcarnitine; Acetylcholinesterase; Alzheimer Disease; Animals; Cognition; Homocysteine; Hyperhom | 2021 |
Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carnitine; Energy Metabolism; Humans; Oxidative Stress | 2020 |
Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer's disease in vitro model.
Topics: Acetylcarnitine; Alzheimer Disease; Animals; Apoptosis; Carnitine; Cells, Cultured; Female; Hippocam | 2021 |
Up-regulation of kinesin light-chain 1 gene expression by acetyl-L-carnitine: therapeutic possibility in Alzheimer's disease.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Axonal Transport; Brain; Gene Ex | 2008 |
Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance.
Topics: Acetylcarnitine; Alzheimer Disease; Animals; Antioxidants; Apolipoproteins E; Cognition Disorders; D | 2009 |
The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease.
Topics: Acetylcarnitine; Aging; Alzheimer Disease; Animals; Antioxidants; Apolipoprotein E4; Brain; Cerebrov | 2009 |
Acetyl-L-carnitine attenuates homocysteine-induced Alzheimer-like histopathological and behavioral abnormalities.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Behavior, Animal; Brain | 2011 |
Beneficial effects of lysosome-modulating and other pharmacological and nanocarrier agents on amyloid-beta-treated cells.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Drug Car | 2012 |
The lowdown on Ginkgo biloba.
Topics: Acetylcarnitine; Acetylcholine; Alzheimer Disease; Animals; Antioxidants; Brain; Candy; Cognition; D | 2003 |
Brain cholinesterases: III. Future perspectives of AD research and clinical practice.
Topics: Acetylcarnitine; Alzheimer Disease; Brain; Cholinesterases; Cytidine Diphosphate Choline; Enzyme Act | 2004 |
Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blotting, Western; Cells, Cultur | 2006 |
Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Topics: Acetylcarnitine; Aldehydes; Alzheimer Disease; Animals; Apoptosis; Cell Survival; Cerebral Cortex; C | 2007 |
Neuroprotective activity of acetyl-L-carnitine: studies in vitro.
Topics: Acetylcarnitine; Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood Physiological Phenomena; C | 1994 |
Acetylcarnitine increases membrane cytoskeletal protein-protein interactions.
Topics: Acetylcarnitine; Alzheimer Disease; Carnitine; Cytoskeletal Proteins; Electron Spin Resonance Spectr | 1993 |
Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine.
Topics: Acetylcarnitine; Alzheimer Disease; Animals; Anti-Bacterial Agents; Brain; Hippocampus; Injections, | 1995 |
Acetyl-L-carnitine.
Topics: Acetylcarnitine; Alzheimer Disease; Animals; Depressive Disorder; Diabetic Neuropathies; HIV Infecti | 1999 |
A 1-year controlled trial of acetyl-L-carnitine in early-onset AD.
Topics: Acetylcarnitine; Alzheimer Disease; Controlled Clinical Trials as Topic; Humans | 2001 |
Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.
Topics: Acetylcarnitine; Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Drug Administrati | 1992 |
Neurophysiological studies of L-acetylcarnitine administration in man.
Topics: Acetylcarnitine; Adult; Aged; Alcoholic Intoxication; Alzheimer Disease; Carnitine; Electroencephalo | 1989 |
Single-photon emission computed tomography studies with 99mTc-hexamethylpropyleneamine oxime in dementia: effects of acute administration of L-acetylcarnitine.
Topics: Acetylcarnitine; Aged; Alzheimer Disease; Carnitine; Dementia; Female; Humans; Injections, Intraveno | 1989 |